Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study aims and inclusion/exclusion criteria for a clinical trial, while retaining the name of the principal investigator and collaborators.SummaryDifference16%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check99 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check106 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.